FitMi AD Home Therapy for Individuals with MCI or Mild Dementia Due to Alzheimer's Disease

Last updated: February 24, 2025
Sponsor: Flint Rehabilitation Devices, LLC
Overall Status: Active - Recruiting

Phase

N/A

Condition

Mild Cognitive Impairment

Memory Problems

Memory Loss

Treatment

FitMi AD

Conventional exercise program

Clinical Study ID

NCT05504811
2R44AG063651-02
  • Ages > 50
  • All Genders

Study Summary

This study will investigate the efficacy of a newly developed exercise device (FitMi AD) for individuals with mild cognitive impairment (MCI) or mild dementia due to Alzheimer's disease. FitMi AD uses embedded sensors that can track and record the patient's direction and degree of movement while performing exercises described on a computer.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • have MCI or mild dementia due to AD (i.e. Clinical Dementia Rating (CDR) score 1 formild dementia or 0.5 for MCI)

  • ability to clearly see the screen and hear the audio instructions from the tablet

  • have a family member or friend who can answer questions about the participant'sdaily living skills

  • willing to participate in a research study.

Exclusion

Exclusion Criteria:

  • age < 50 years old

  • use of a wheelchair as a primary mobility device (use of a cane or walker ispermitted)

  • presence of other neurologic conditions such as movement disorders or history ofstroke

  • other severe concurrent medical conditions that may prevent the participants fromcompleting the 3-month study

Study Design

Total Participants: 30
Treatment Group(s): 2
Primary Treatment: FitMi AD
Phase:
Study Start date:
March 01, 2023
Estimated Completion Date:
April 17, 2025

Connect with a study center

  • Rancho Research Institute, Inc

    Downey, California 90242
    United States

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.